TAG:
PathAI
April 25, 2022 Intelligence: Late-Breaking Lab News
In a sign that awareness of medical diagnostic testing continues to grow during the SARS-CoV-2 pandemic, the Mayo Clinic announced it will invest $49 million to build a new laboratory space on its campus in Rochester, Minn. As part of the multi-year project, several clinical labs will eventual…
Pathology Firm’s Investment in AI Signals a New Trend
This is an excerpt of a 1,436-word article in the February 22, 2022 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple inve…
Pathology Investment in AI Signals New Trend
CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple investors, including both Sonic Healthcare—Australia’s largest pathology group—and I-MED Radiology Network. Pathology’s growing interest in AI tools, along with the grow…
First Digital Path AI Tool Cleared for Market by FDA
CEO SUMMARY: In a first for the anatomic pathology profession, the Food and Drug Administration (FDA) has cleared for market a digital pathology image analysis product intended to aid pathologists in the diagnosis of prostate cancer. Developed by New York City-based Paige, the Paige…
PathAI Buys Poplar Health, Creates Unique Company
CEO SUMMARY: Pathologists were surprised this summer when a company developing image analysis software announced the acquisition of one of the nation’s largest independent anatomic pathology (AP) laboratories. The technology company PathAI is now the owner of Poplar Healthcare Man…
Labcorp Now Using AI for Operations, Patient Care
CEO SUMMARY: In recent years, Labcorp invested significant sums to use artificial intelligence and machine learning technologies—often integrated with robotic systems—to improve work processes and gain real-time insights from vast amounts of data. In this exclusive interview, La…
CURRENT ISSUE
Volume XXX, No. 13 – September 11, 2023
Recent court rulings involving the No Surprises Act are putting the government on the defensive about provisions of the law. Also, the continued consolidation of the IVD and national laboratory company markets has brought more influence to those lab companies. In addition, learn how clinical labs can earn money from their diagnostic data by helping private insurers navigate Medicare Advantage’s risk adjustment model.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.